Market Share Intelligence
Small UK Pharma
Providing new market insights with limited client data
Our client approached us as they required a deeper understanding of their market share but faced significant data limitations. As a small pharmaceutical company, they did not have the scale of budget required for competitor market datasets from large data providers and as such relied solely on wholesaler shipment data.
Due to an upcoming launch in several new therapeutic indications, they needed additional market insights to support planning and launch excellence.
CSL enriched the available client data with NHS prescribing data
Our solution was to compliment their wholesaler shipment data with NHS Open Data, in this instance from our proprietary Secondary Care Market Dynamics (SCMD) database. This provided our client with a cost-effective view of the competitor market.
This enabled us to compare shipment and prescribing data by product, offering a comprehensive view of market shares and trends.
A standout aspect of this project was overcoming the complexities of data discrepancies. Matching wholesaler customer descriptions to NHS trusts was a complex and manual task, since many trust postcodes do not match with delivery sites.
Bespoke analysis and expert health data knowledge transformed our clients data
The insights delivered by CSL provided our client with detailed insights into their business at the NHS trust and Integrated Care Board (ICB) levels. Additionally, it allowed them to understand market sizes within specific indications using a cost-effective dataset, equipping them with long term intelligence for effective decision-making.
The client was highly satisfied with our work, praising our responsiveness and meticulous attention to detail throughout the project. This collaboration highlights how tailored data solutions can transform limited information into powerful market insights.
CSL are passionate in helping clients unlock the value of data by providing expert consultancy and tailored BI solutions. As we continue to expand our knowledge and capabilities, we remain dedicated to driving BI innovation and excellence within the industry.